ÂÜÀòÂÒÂ×

The Clinical Development Team at Olema Oncology is responsible for the strategic planning, execution, and management of clinical trials, including the ongoing Phase 1/2 trial of OP-1250. This team ensures the rigorous design and implementation of clinical studies while maintaining compliance with regulatory standards. Their collective efforts aim to advance OP-1250 through the clinical development pipeline, ultimately contributing to the availability of innovative therapies for women's cancers.